sucralfate tablet

INDICATIONS AND USAGE Sucralfate tablets are indicated in: Short-term treatment (up to 8 weeks) of active duodenal ulcer. While healing with sucralfate may occur during the first week or two, treatment should be continued for 4 to 8 weeks unless healing has been demonstrated by x-ray or endoscopic examination. Maintenance therapy for duodenal ulcer patients at reduced dosage after healing of acute ulcers.

amneal pharmaceuticals ny llc

FDA Reported Adverse Reactions
`[1] drug ineffective` `[2] pain` `[3] fatigue` `[4] nausea` `[5] headache` `[6] dyspnoea` `[7] diarrhoea` `[8] vomiting` `[9] arthralgia` `[10] pyrexia`

2 years ago

OVAL PINK A56

HOW SUPPLIED

SUCRALFATE tablets, USP 1 g are available as light pink, oblong tablets debossed with “A56” on one side and plain on the other side with a score line. They are supplied as follows: Bottles of 100 with child-resistant closure: NDC 69238-1656-1 Bottles of 500 with child-resistant closure: NDC 69238-1656-5 Store at 20° to 25°C (68° to 77°F); excursions permitted between 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature]. Rx Only Distributed by: Amneal Pharmaceuticals LLC Bridgewater, NJ 08807 Rev. 05-2021-01 www.amneal.com

More pills like OVAL A56

Related Pills

carvedilol 6.25 mg

advagen pharma ltd

carvedilol 6.25 mg

advagen pharma ltd

etravirine tablet 25 mg

amneal pharmaceuticals ny llc

DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site

sucralfate tablet

FDA Reported Adverse Reactions [1] drug ineffective [2] pain [3] fatigue [4] nausea [5] headache [6] dyspnoea [7] diarrhoea [8] vomiting [9] arthralgia [10] pyrexia

OVAL PINK A56

More pills like OVAL A56

Related Pills

carvedilol 6.25 mg

carvedilol 6.25 mg

etravirine tablet 25 mg

FDA Reported Adverse Reactions
`[1] drug ineffective` `[2] pain` `[3] fatigue` `[4] nausea` `[5] headache` `[6] dyspnoea` `[7] diarrhoea` `[8] vomiting` `[9] arthralgia` `[10] pyrexia`